ReviewCurrent treatment options in oncology2024

Neoadjuvant Therapy: Current Landscape and Future Horizons for ER-Positive/HER2-Negative and Triple-Negative Early Breast Cancer.

Hervé Bischoff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.